Regulus Therapeutics

RGLS

RGLS Regulus Therapeutics NASDAQ
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Financials
    News
    Filings
    Profile
    RGLS Chart
    See on advanced chart >

    About

    Regulus Therapeutics Inc. was formed in September 6, 2007.The company is a clinical-stage biopharmaceutical company focused on discovering and developing first-in-class drugs targeting microRNAs to treat diseases with significant unmet medical need.
    • Highlight
      A biopharmaceutical company that developing therapeutics to target microRNAs
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      10/04/2012
    • Established Date
      09/06/2007
    • Full-time Employees
      30
    • Address
      4224 Campus Point Court Suite 210 San Diego CA 92121
    • Tel
      1-858-2026300
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock
    cache time: 2024-02-22 10:28:27